United Kingdom
UK / English
Choose your region
Choose your language
Register
Mast_Group.svg
ProductsMarketsAboutNews & EventsResourcesCareers
Contact us
ProductsMarketsAboutNews & EventsResourcesCareers
logo-mast.svg
+44 (0) 151 933 7277
Email us
Sign up to Newsletter
Products
  • Gastrointestinal Diseases
  • Immunology
  • Microbiology
  • Molecular
  • Pharmaceutical Services
  • Urinalysis
Markets
  • Clinical Diagnostics
  • FIT testing
  • Infectious Disease
  • Pharmaceutical & Industrial
  • Veterinary
About
  • Our Culture
  • Our Governance
  • Our History
  • Our Locations
  • Our Partners
  • Our Quality
Resources
  • FAQs
  • Certificates of Analysis
  • Quality Certification
News & Events
  • News
  • Events
  • Blog
United Kingdom
UK / English
Manage Cookies|
Terms & conditions|
Data Protection|
Ordering Information|
Conditions of Purchase|
Modern Slavery
|Update cookie preferences|© Mast Group Ltd. 2026 Mast Group Limited is a limited company registered in England and Wales with registered number 00632512. Our registered office is at Mast House, Derby Road, Liverpool, L20 1EA.
Follow Us
LinkedIn.svgUK
© Mast Group Ltd. 2026 Mast Group Limited is a limited company registered in England and Wales with registered number 00632512. Our registered office is at Mast House, Derby Road, Liverpool, L20 1EA.
Home
Syndromic PCR AssaysTuberculosis

Tuberculosis

Human Papilloma Virus (HPV)

Gastrointestinal Sexually Transmitted Infections (STI)RespiratoryHuman Papilloma Virus (HPV)Healthcare Acquired Infection (HAI)MeningitisTuberculosisMiscellaneousExtraction

Rapid nucleic acid amplification tests (NAATs) to detect M.tuberculosis DNA and multi-line drug resistance. Rapid turn around times compared with traditional culture.

Allplex™ MTB/MDRe Detection
Syndromic PCR Assays
Allplex™ MTB/MDRe Detection
TB9400X
Allplex™ MTB/MDRe Detection is a qualitative real-time PCR in vitro diagnostic test for single or multiple detection of Mycobacterium tuberculosis (MTB) and its resistance to first-line anti-tuberculosis drugs (Isoniazid and Rifampicin) in sputum, culture, and bronchial washing specimens, obtained from individuals exhibiting signs and/or symptoms of a Mycobacterium tuberculosis infection. The test is intended for use as an aid in the diagnosis Mycobacterium tuberculosis infection if used in conjunction with other clinical and epidemiological information.
More Info